RecruitingNot applicableNCT04224064
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
Studying Well-differentiated liposarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Principal Investigator
- Nelly FIRMIN, MDInstitut Régional du Cancer de Montpellier (ICM)
- Intervention
- Blood sampling(diagnostic_test)
- Enrollment
- 158 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2029
Study locations (1)
- Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04224064 on ClinicalTrials.govOther trials for Well-differentiated liposarcoma
Additional recruiting or active studies for the same condition.